Format

Send to

Choose Destination
Cell. 2012 Jun 8;149(6):1185-7. doi: 10.1016/j.cell.2012.05.019.

Target practice: modeling tumors with stem cells.

Author information

1
Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, 94158, USA.

Abstract

A variant neoplastic line of human pluripotent stem cell (hPSC) displays unique tumorigenic properties, including enhanced self-renewal and survival, and aberrant blockade in differentiation. Sachlos et al. adopted a neoplastic hPSC differentiation platform to screen small molecules that selectively induce differentiation of cancer stem cells.

PMID:
22682241
DOI:
10.1016/j.cell.2012.05.019
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center